Terrence O. Tormey
Mr. Tormey has been President and Chief Executive Officer of Prevention Pharmaceuticals Inc since July 1, 2010. Mr. Tormey has more than 35 years of sales and marketing experience in the global pharmaceutical and OTC product markets. From 1976 to 1985, he was Director, Sales Staff Management with Johnson & Johnson; from 1985 to 1990, he was A.V.P. Medical/Hospital Sales with Wyeth, (later known as Pfizer).
Mr. Tormey was associated with Nelson Communications Worldwide from 1990 to 2003. In 1990 he joined Professional Detailing Network as its VP-Sales. Later he served as President of The Medical Phone Company, and finally, President/COO of Nelson Professional Sales (now Touch Point Solutions), a division of Publicis, SA, Paris. In 2005 he was Co-Founder and President/COO of LifeGuard Health LLC (now PRN Products); and was Senior Vice-President of Business Development for North America at Innovex, Division of Quintiles Transnational between 2006 and 2007. From 2003 to 2011, he was the Founder/President of The Tormey Consulting Group.
Mr. Tormey received his bachelor of science degree in biology from Saint Vincent College, Latrobe, PA, in 1976. He did additional course work at the Wharton School, Duke University Fuqua School, and Duke Law.
While at Johnson and Johnson, Mr. Tormey was a member of the Professional Field Sales Management Team, which was responsible for the recovery of the Tylenol® Brand after the Chicago cyanide poisonings. While at Wyeth, he worked on the Professional launch of Advil®. His sales management experience includes some of the most widely recognized brand name prescription and OTC products in the US, including Aricept®, Cipro®, Coumadin®, Excedrin Migraine®, Flonase®, Gyne-Lotrimin®, Lamictal®, Monistat-7®, Ortho-Novum®, Plendil®, Ritalin® Sinemet® CR, Ultram®, and Zantac®.
Additionally, Mr. Tormey serves on the Board of Directors of EuroMed, Inc, and BioVid. He is a member of the National Association of Corporate Directors (NACD).